SPATA9 Antikörper (N-Term)
-
- Target Alle SPATA9 Antikörper anzeigen
- SPATA9 (Spermatogenesis Associated 9 (SPATA9))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Rind (Kuh), Hund, Pferd, Meerschweinchen, Ratte, Maus, Kaninchen
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SPATA9 Antikörper ist unkonjugiert
- Applikation
- Western Blotting (WB)
- Sequenz
- PIKPVGWICG QVLKNFSGRI EGIQKAIMDL VDEFKDEFPT ILRLSQSNQK
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 85%, Rabbit: 92%, Rat: 100%
- Produktmerkmale
- This is a rabbit polyclonal antibody against SPATA9. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human SPATA9
- Top Product
- Discover our top product SPATA9 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 254 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study." in: Journal of thrombosis and haemostasis : JTH, Vol. 4, Issue 6, pp. 1228-36, (2006) (PubMed).
: "
-
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study." in: Journal of thrombosis and haemostasis : JTH, Vol. 4, Issue 6, pp. 1228-36, (2006) (PubMed).
-
- Target
- SPATA9 (Spermatogenesis Associated 9 (SPATA9))
- Andere Bezeichnung
- SPATA9 (SPATA9 Produkte)
- Synonyme
- SPATA9 antikoerper, NYD-SP16 antikoerper, 1700030K01Rik antikoerper, 4930599C08Rik antikoerper, A930023H06Rik antikoerper, spermatogenesis associated 9 antikoerper, SPATA9 antikoerper, Spata9 antikoerper
- Hintergrund
-
SPATA9 may play a role in testicular development/spermatogenesis and may be an important factor in male infertility. Defects in expression of SPATA9 lead to Sertoli-cell-only syndrome.
Alias Symbols: FLJ35906, NYD-SP16
Protein Size: 254 - Molekulargewicht
- 29 kDa
- Gen-ID
- 83890
- NCBI Accession
- NM_031952, NP_114158
- UniProt
- Q9BWV2
-